Louisville, Ky.
The National Institutes of Health's National Institute for Allergy and Infectious Diseases (NIAID) has awarded the University of Louisville a $22 million federal grant to construct a biodefense research laboratory on its Shelby campus. One of thirteen BSL-3 Regional Biosafety Laboratories in the nation funded by NIAID since 2003, the 45,000-sf facility will be supported by $12.6 million in University funding. The building will house the University's Center for Predictive Medicine.
